Introduction
Neonatal lung disease after premature birth has been associated with long term pulmonary sequelae. Bronchial hyperreactivity, e.g., has been found in school children following long term ventilation during the neonatal period [11] and following bronchopulmonary dysplasia [1, 15] . A high incidence of airway hyperreactivity has also been described in children after premature birth without respiratory distress syndrome and in a high proportion of their mothers and siblings born at term [2] . As a relationship between familial airway hyperreactivity and premature birth was suggested by this work, it seemed important to further investigate mothers of preterm infants. It was the purpose of the present study to compare bronchial responsiveness to histamine among mothers of term infants and preterm infants with known and with unknown causes for prematurity. 
Material and methods
Pulmonary function tests were performed in all mothers of neonates admitted to our neonatal ward during the years 1984-1987 provided informed consent was obtained and the following criteria were met: Non-smoker for at least two years before pregnancy; no atopic disease (asthma, hay fever, eczema) including first degree relatives; no chronic lung disease; no acute airway infection during the preceeding 6 weeks; serum IgE < 100 lU/ml (Enzygnost ELISA, Behringwerke, Marburg, FRG); negative Type I skin reactions by prick test to 10 common inhalation allgergens (house dust mite, different pollen allergens, feathers, moulds).
The 60 mothers who participated in the study were separated into three groups: Group I, mothers of term neonates (> 37 weeks of gestation) n = 20; Group II, mothers of preterm neonates (< 37 weeks of gestation) with unknown cause of prematurity (idiopathic) n = 18; Group III, mothers of preterm neonates in whom premature labour could be explained by some definite reason as defined below, n = 22.
Groups II and III were recruited from consecutive admissions in the years 1984-1987, whereas group I came from consecutive admission only in 1987.
As explanations for preterm delivery were excepted: Multiple pregnancy, young age (< 16 years) or advanced age (> 35 years), premature rupture of the fetal membranes without labour, abdominal trauma, intrauterine infection, abnormal placentation, structural uterine abnormalities, congenital malformations, EPH-gestosis, polyhydramnion, severe maternal illness during pregnancy and Rhesus-incompatibility.
The gestational age of the neonates was determined on the day of birth using the Farr-criteria Π-Pulmonary function tests were performed at least four weeks after delivery and included vital capacity, functional residual capacity, residual volume, airway resistance and thoracic gas volume (bodyplethysmography) and forced expiratory flow measurements as described elsewhere [12] .
Bronchial reactivity was measured by unspecific provocation testing with inhaled histamine using a modified version of the protocol described by Cockroft et al. [6] . Histamine dihydrochloride in buffered saline was nebulized in a 10 Itr reservoir by pressure nebulizer (Pari, Starnberg, FRG, particle size 0.5 -5mm, output 0.75 ml/min) with increasing concentrations (0.5 -1-2 -4 -8 mg/ ml). To fill the reservoir, 0.75 ml of histamine solution and 120 sec of nebulization were necessary. When the reservoir was filled, the nebulized aerosol was inhaled by tidal ventilation through a one way valve.
One and three minutes after the inhalation forced expiratory maneuvers were performed using a pneumotachygraph (Pneumoscreen, Maeger, FRG) and the best of three attempts, i. e. with the highest forced expiratory volume, was used for analysis. The histamine concentration producing a 20% fall in forced expiratory volumes in 1 second (PC 2 o,FEv 1 ) was determined from a semi-logarithmic dose-response curve.
All investigations were performed in the afternoon when bronchial reactivity is at its low part of circadian variation.
A PC 2 o,FEvrvalue < 8 mg/ml histamine was assumed to represent airway hyperreactivity according to population studies [4]. PC20.FEV, -figures were compared between the three groups using the Wilcoxon-Mann-Whitney-test; for comparison of the incidence of airway hyperreactivity (as defined above) we used FISCHER'S exact test.
Results
Age and number of previous pregnancies did not differ among the three groups as shown in the table.
Basic pulmonary function tests were within normal limits in all investigated mothers, but bronchial reactivity differed significantly in group II (PC 2 o 5 FEv 1 = 4.25 (0.9-> 8.0) mg/ml histamine, median and range) from both other groups (group Ι, PC20.FEV, = > 8.0 (0.55-> 8.0) mg/ml, ρ < 0.002; group III, PC 2 o, FE v 1 = > 8.0 (1.5-< 8.0) mg/ml, p < 0.05; figure) Accordingly, the incidence of bronchial hyperreactivity was significantly higher in group II (12 of 18) than in group I (3 of 20, ρ < 0.02), the latter corresponding to the normal incidence of airway hyperreactivity in a healthy population [4], Between group II and III the incidence of bronchial hyperreactivity was not statistically different (p = 0.55), although more hyperreactive mothers were found in group II (12 of 18 vs. 8 of 22).
One of the three mothers in group I with increased bronchial reactivity (PC 20 ,FEV! of 3.7 mg/ml histamine) reported having had some mild uterine contractions at 26 th week of gestation which ceased spontaneously. Table I . Age and numbers of previous pregnancies among the three groups (not different). 
Discussion
Mothers with preterm delivery of unknown cause (idiopathic prematurity) have a significantly increased airway reactivity compared to both mothers of term neonates and mothers of preterm neonates with a defined cause of preterm delivery.
The high incidence of bronchial hyperreactivity in mothers with preterm delivery of unknown origin cannot be explained by one of the factors which are known to be associated with increased bronchial reactivity (atopy, smoking, chronic lung disease, recent airway infection, etc.) as these factors were part of the exclusion criteria for the study.
The effect of pregnancy on bronchial reactivity is not known, but as bronchial reactivity was measured at least four weeks after delivery an influence of pregnancy is unlikely.
Although due to strict exclusion criteria the numbers in each group are small, bronchial reactivity is obviously highest in the mothers with unexplained prematurity. The WILCOXON test, which we used for statistical analysis in addition to FISCHER'S exact test, has its limitation due to zensored values above PC 2 o,FEv, of 8 mg/ml histamine. When using this method for measuring bronchial reactivity, it does not seem justified to further increase histamine concentrations in healthy women above 8 mg/ml until significant bronchial obstruction occurs, as non specific side effects occur (e.g. cough, flush, throat irritation and headache) under these circumstances before bronchial obstruction is observed.
One of the hypotheses about the pathogenesis of bronchial hyperreactivity implies an imbalance within the autonomic nervous system [3] which has an important role in uterine innervation and function [13] . Beta-2-agonists, the drugs of first choice in bronchial asthma, are the main agents for inhibition of premature labour [10] . Furthermore, the potent bronchoconstrictor Prostaglandin F2a [14] , is one of the main mediators responsible for cervical softening and uterine contractions in premature delivery [8] .
Thus, a similar basic mechanism influencing uterine and airway smooth muscle activity may be operating in some women leading to airway hyperresponsiveness and premature labor.
As bronchial hyperreactivity is partly inherited [9] , airway hyperresponsiveness in the preterm neonates of these mothers may not entirely be explained by acquired lung damage due to prematurity, oxygen treatment or neonatal ventilation, but may also be related to a genetically determined bronchial hyperreactivity.
This may also explain why premature infants, even in the absence of BPD have a higher morbidity following RSV-and other respiratory tract viral infections [5] . They represent a risk group for later bronchial disease, not due to early bronchial damage but due to inherited bronchial hyperreagibility, and should be followed up carefully in this regard.
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Bronchial reactivity was compared among mothers of neonates with unexplained premature delivery and mothers of preterm neonates with known etiology of prematurity as well as mothers who deliverd their children at term. Bronchial reactivity was measured by unspecific bronchial provocation testing with histamine.
A significantly higher incidence of bronchial hyperreactivity was found among mothers with unexplained prematurity as compared to the control groups. An imbalance in the autonomic nerve system leading to prematurity as well as bronchial hyperresponsiveness is suggested.
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